Literature DB >> 27374776

Assessment of drug-induced proarrhythmia: The importance of study design in the rabbit left ventricular wedge model.

Hua Rong Lu1, David J Gallacher2, Gan-Xin Yan3.   

Abstract

In the present study, we investigated an impact of the stimulation rate on the detection of the proarrhythmic potential of 10 reference compounds with effects on different cardiac ion channels in the isolated arterially-perfused rabbit left ventricular wedge preparation. The compounds were tested in the wedge model using two distinct protocols; including baseline stimulation at 1-Hz followed by a brief period at 0.5-Hz, either without an additional brief period of 2-Hz stimulation (i.e. Protocol 1) or with 2-Hz stimulation (i.e. Protocol 2). As expected, QT-prolonging drugs (ibutilide and quinidine) prolonged the QT interval, similarly increased the Torsades de Pointes (TdP) score, and elicited early afterdepolarizations (EADs) in both protocols. HMR1556 and JNJ-303 (IKs blockers) also prolonged the QT interval up to 1μM similarly in both protocols. Nifedipine (Ca(2+) antagonist) shortened the QT interval, and reduced force of contraction similarly in both protocols. However, Na(+) channel blockers (Ia, Ib, Ic) widened the QRS duration more in Protocol 2 than in Protocol 1. Furthermore, it was only possible to detect non-TdP-like ventricular tachycardia/fibrillation (VT/VF) induced by Na(+) blockers and by QT-shortening drugs (levcromakalim and mallotoxin) using the 2-Hz stimulation (Protocol 2). Our data suggest that the inclusion of a brief period of fast stimulation at 2Hz is critical for detecting drug-induced slowing of conduction (QRS widening), QT shortening and associated (non-TdP-like) VT/VF, which are distinct from the QT prolongation/TdP proarrhythmia in isolated, arterially-perfused rabbit left ventricular wedges.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac arrhythmias; Drug; Long QT syndrome; Short QT syndrome; Stimulation rate; TdP: Torsades de Pointes; VF: ventricular fibrillation; VT: ventricular tachycardia

Mesh:

Substances:

Year:  2016        PMID: 27374776     DOI: 10.1016/j.vascn.2016.06.006

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  3 in total

1.  Identifying Acute Cardiac Hazard in Early Drug Discovery Using a Calcium Transient High-Throughput Assay in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Hua Rong Lu; Mohamed Kreir; Van Ammel Karel; Fetene Tekle; Danny Geyskens; Ard Teisman; David J Gallacher
Journal:  Front Physiol       Date:  2022-04-25       Impact factor: 4.755

2.  Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity.

Authors:  Elisa Passini; Oliver J Britton; Hua Rong Lu; Jutta Rohrbacher; An N Hermans; David J Gallacher; Robert J H Greig; Alfonso Bueno-Orovio; Blanca Rodriguez
Journal:  Front Physiol       Date:  2017-09-12       Impact factor: 4.566

3.  Classifying Drugs by their Arrhythmogenic Risk Using Machine Learning.

Authors:  Francisco Sahli-Costabal; Kinya Seo; Euan Ashley; Ellen Kuhl
Journal:  Biophys J       Date:  2020-01-22       Impact factor: 4.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.